GSA CAPITAL PARTNERS LLP - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$2,123,000
+51.4%
50,240
+38.9%
0.08%
+46.4%
Q1 2015$1,402,000
+58.6%
36,158
+37.7%
0.06%
-9.7%
Q4 2014$884,000
-36.4%
26,266
-33.8%
0.06%
-15.1%
Q3 2014$1,389,000
+39.6%
39,666
+31.1%
0.07%
+62.2%
Q2 2014$995,000
+28.1%
30,266
+43.5%
0.04%
-18.2%
Q1 2014$777,000
-23.0%
21,088
-19.8%
0.06%
-31.2%
Q4 2013$1,009,000
-4.9%
26,288
-32.1%
0.08%
-4.8%
Q3 2013$1,061,000
+44.7%
38,734
+11.0%
0.08%
-3.4%
Q2 2013$733,00034,9050.09%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders